Deep-lung Targeting
Deep-Lung Targeting is a drug delivery strategy that specifically directs inhaled aerosolized therapeutics to the distal regions of the respiratory tract, distinguishing itself by maximizing deposition in the alveolar airspaces while minimizing proximal airway retention.
14
Publications
1.3K
Citations
94
Authors
36
Institutions
Publications per year
2017–2026
4
Parents
14
Joseph Hanley, Marc M. Debois, Dennis Mah et al. · International Journal of Radiation Oncology*Biology*Physics · 1999 · 602 citations
1–5 of 14
94
2
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 94
36
UCLouvain
Louvain-la-Neuve, Belgium
2 h-index
6 publications
350 citations

University of Groningen
Groningen, The Netherlands
1 h-index
6 publications
150 citations
Io Therapeutics (United States)
Santa Ana, United States
1 h-index
2 publications
48 citations
Arkansas Cardiology
Little Rock, United States
1 h-index
1 publications
24 citations
State University of New York
Albany, United States
1 h-index
2 publications
56 citations

Monash University
Melbourne, Australia
1 h-index
1 publications
24 citations
The University of Texas at Austin
Austin, United States
1 h-index
4 publications
268 citations
NYU Langone Health
New York, United States
1 h-index
1 publications
24 citations
1–8 of 36
2 publications · 718 citations
2
h-index
2 publications · 92 citations
2
h-index
1 publications · 257 citations
1
h-index
1 publications · 20 citations
1
h-index
1 publications · 29 citations
1
h-index
1–5